Efrat Shema

Rehovot, M 76100, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

SM-NucSeq, Genetic and Epigenetic Sequencing of Nucleosomes with Single-Molecule Real-Time Sequencing.

SM-NucSeq, Genetic and Epigenetic Sequencing of Nucleosomes with Single-Molecule Real-Time Sequencing.

Journal: Nano letters

Published: March 18, 2026

p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer.

p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 29, 2025

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma.

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma.

Journal: PLoS biology

Published: January 23, 2025

Oncogenic IDH1mut drives robust loss of histone acetylation and increases chromatin heterogeneity.

Oncogenic IDH1mut drives robust loss of histone acetylation and increases chromatin heterogeneity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 10, 2025

Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas.

Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas.

Journal: eLife

Published: August 02, 2024

Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Journal: Nature metabolism

Published: July 04, 2024

Cancer Hallmarks: Piecing the Puzzle Together.

Cancer Hallmarks: Piecing the Puzzle Together.

Journal: Cancer discovery

Published: April 04, 2024

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function.

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function.

Journal: Cancer cell

Published: March 21, 2024

Single-molecule systems for detection and monitoring of plasma circulating nucleosomes and oncoproteins in Diffuse Midline Glioma.

Single-molecule systems for detection and monitoring of plasma circulating nucleosomes and oncoproteins in Diffuse Midline Glioma.

Journal: bioRxiv : the preprint server for biology

Published: December 04, 2023

Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.

Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.

Journal: Cell reports. Medicine

Published: November 14, 2023

ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Journal: Nature metabolism

Published: July 23, 2023

A single-molecule liquid biopsy for cancer diagnosis.

A single-molecule liquid biopsy for cancer diagnosis.

Journal: Nature reviews. Cancer

Published: March 27, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026